An arrhythmia is a problem with the speed or rhythm of the heartbeat. Atrialfibrillation (AF) is the most common type of arrhythmia. The cause is a disorder in the heart's electrical system.
Often, people who have AF may not even feel symptoms. But you may feel
Palpitations -- an abnormal rapid heartbeat
Shortness of breath
Weakness or difficulty exercising
Dizziness or fainting
AF can lead to an increased risk of stroke. In many patients, it can also cause chest pain, heart attack, or heart failure.
Doctors diagnose AF using family and medical history, a physical exam, and a test called an electrocardiogram (EKG), which looks at the electrical waves your heart makes. Treatments include medicines and procedures to restore normal rhythm.
NIH: National Heart, Lung, and Blood Institute
Check out the latest treatments for ATRIAL FIBRILLATION
Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Percentage of patient with a cessation of seizures and absence of recurrence; Duration between the first cessation and the recurrence of seizures; Percentage of patients having had a second injection of benzodiazepine; Percentage of patients having had an injection of the second line treatment; Percentage of patients having a general anesthesia for refractory status epilepticus; Percentage of patients having had a side effect; Percentage of patients having been mechanically ventilated; Glasgow Coma Scale; Mortality; Length of stay in Intensive Care Unit; Length of stay in hospital
o Uneventful intravenous (iv) administration of study medication; o Toxicity profile on iv administration, including:; § Irritation on injection site; § Hypotension, defined as systolic blood pressure below 90 mm Hg recorded within 24 hours of the dose; § Cardiac arrest (diagnosed clinically) or bradyarrhythmias including heart block, documented on an electrocardiogram; § Respiratory depression, defined as the occurrence of apnea or need for intubation; § Allergic reactions, like skin rash; § Other side-effects; Pharmacokinetic parameters of levetiracetam and clonazepam in patients with SE